Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.89
(-2.2%)
HKD 0.89
(-2.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 99.27 Million CNY | 4.92% |
| 2022 | 94.62 Million CNY | 17.36% |
| 2021 | 80.62 Million CNY | 10.12% |
| 2020 | 73.21 Million CNY | 14.46% |
| 2019 | 63.96 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 38.27 Million CNY | 68.72% |
| 2023 Q4 | 99.27 Million CNY | 12.15% |
| 2023 FY | 99.27 Million CNY | 4.92% |
| 2023 Q2 | 88.51 Million CNY | -6.45% |
| 2022 FY | 94.62 Million CNY | 17.36% |
| 2022 Q2 | 78.91 Million CNY | -2.12% |
| 2022 Q4 | 94.62 Million CNY | 19.9% |
| 2021 Q2 | 75.57 Million CNY | 3.22% |
| 2021 FY | 80.62 Million CNY | 10.12% |
| 2021 Q4 | 80.62 Million CNY | 6.68% |
| 2020 FY | 73.21 Million CNY | 14.46% |
| 2020 Q4 | 73.21 Million CNY | 20.17% |
| 2020 Q2 | 60.92 Million CNY | -4.75% |
| 2019 FY | 63.96 Million CNY | 0.0% |
| 2019 Q4 | 63.96 Million CNY | -9.34% |
| 2019 Q2 | 70.55 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -4688.956% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 89.973% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 15.239% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 64.057% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -40.544% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -175.33% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -675.525% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -22.421% |
| SSY Group Limited | 1.94 Billion HKD | 94.903% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -126.655% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 83.236% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.403% |